Stocksigma LogoStocksigma Logo

Gaudium IVF Q2 FY27 Consolidated Results and IPO Object Revision

Gaudium IVF reported consolidated revenue of ₹3,741.11 lakhs for the quarter ended 30th Sep'26, up 17.9% YoY and 93.1% QoQ

Gaudium IVF Q2 FY27 Consolidated Results and IPO Object Revision

Gaudium IVF and Women Health Ltd · Change in Management · 13 Nov 2026, 2:26 am

Gaudium IVF Q2 FY27 Consolidated Results and IPO Object Revision Gaudium IVF reported consolidated revenue of ₹3,741.11 lakhs for the quarter ended 30th Sep'26, up 17.9% YoY and 93.1% QoQ. Consolidated net profit reached ₹941.31 lakhs compared to ₹937.91 lakhs in the year-ago period and ₹177.59 lakhs in Q1 FY27, with diluted EPS at ₹1.29. The Board approved substituting 6 locations and revising the timeline to establish 19 new IVF centres by FY29 within the existing ₹5,000 lakhs IPO allocation, alongside appointing Dr. Ravish Manchanda as National Head – Operations Expansion & Strategy.

Original exchange filing (PDF)

More announcements from Gaudium IVF and Women Health Ltd

All Gaudium IVF and Women Health Ltd announcements